Riskpilot← Back to searchSign inGet full accessLC Läkarkonsult AB
ABIn liquidationOrg 5569586968Medical specialists activities · NACE 8622Est. 20141 employees
Revenue 2022
SEK 0
EBITDA margin
—
-20% vs 2021
Equity ratio
100.0%
Financial strength
Net profit 2022
SEK -12K
-20% vs 2021
| Revenue | SEK 0 | — |
| EBITDA | SEK -12K | -20% |
| Net profit | SEK -12K | -20% |
| Total assets | SEK 18K | -40% |
| Equity | SEK 18K | -40% |
| Employees | 1 | — |
Legal name
LC Läkarkonsult AB
Org number
5569586968
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
16 januari 2014
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget ska bedriva verksamhet inom öppen hälso och sjukvård, medicinska konsultationer och därmed förenlig verksamhet. Bolaget ska också bedriva handel med värdepapper samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 230 | 83 | 6 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 46 | −35 | −9 | −10 | −12 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 46 | −35 | −9 | −10 | −12 |
| Net financials | — | — | −1 | — | — |
| Profit before tax | 35 | −9 | −10 | −10 | −12 |
| Tax | −8 | −0 | −0 | −0 | −0 |
| Net profit | 27 | −9 | −10 | −10 | −12 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 151 | 69 | 43 | 30 | 18 |
| Equity | 89 | 50 | 40 | 30 | 18 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 35 | 18 | 2 | 0 | 0 |
| Total debt | 35 | 18 | 2 | — | — |
EBITDA margin
-1200000.0%
This company
15.8%
Market median
-7595037% vs market
20182022
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20182022
Return on equity
-66.7%
This company
18.4%
Market median
-463% vs market
20182022
Net profit margin
-1200000.0%
This company
8.1%
Market median
-14814915% vs market
20182022
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20182022
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20182022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AC Liquidator | Liquidator | 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Board of Directors | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LC Läkarkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Azra Custovic | Liquidator | 0 companies |
| Lejla Custovic | Board of Directors | 0 companies |
| Aida Custovic | Deputy Board Member | 0 companies |